The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Neurobiologic Advances from the Brain Disease Model of Addiction
Open accessAbstract
This article reviews scientific advances in the prevention and treatment of substance-use disorder and related developments in public policy. In the past two decades, research has increasingly supported the view that addiction is a disease of the brain. Although the brain disease model of addiction has yielded effective preventive measures, treatment interventions, and public health policies to address substance-use disorders, the underlying concept of substance abuse as a brain disease continues to be questioned, perhaps because the aberrant, impulsive, and compulsive behaviors that are characteristic of addiction have not been clearly tied to neurobiology. Here we review recent advances in the neurobiology of addiction to clarify the link between addiction and brain function and to broaden the understanding of addiction as a brain disease. We review findings on the desensitization of reward circuits, which dampens the ability to feel pleasure and the motivation to pursue everyday activities; the increasing strength of conditioned responses and stress reactivity, which results in increased cravings for alcohol and other drugs and negative emotions when these cravings are not sated; and the weakening of the brain regions involved in executive functions such as decision making, inhibitory control, and self-regulation that leads to repeated relapse. We also review the ways in which social environments, developmental stages, and genetics are intimately linked to and influence vulnerability and recovery. We conclude that neuroscience continues to support the brain disease model of addiction. Neuroscience research in this area not only offers new opportunities for the prevention and treatment of substance addictions and related behavioral addictions (e.g., to food, sex, and gambling) but may also improve our understanding of the fundamental biologic processes involved in voluntary behavioral control. In the United States, 8 to 10% of people 12 years of age or older, or 20 to 22 million people, are addicted to alcohol or other drugs. 1 The abuse of tobacco, alcohol, and illicit drugs in the United States exacts more than $700 billion annually in costs related to crime, lost work productivity, and health care. 2-4 After centuries of efforts to reduce addiction and its related costs by punishing addictive behaviors failed to produce adequate results, recent basic and clinical research has provided clear evidence that addiction might be better considered and treated as an acquired disease of the brain (see Box 1 for definitions of substance-use disorder and addiction). Research guided by the brain disease model of addiction has led to the development of more effective methods of prevention and treatment and to more informed public health policies. Notable examples include the Mental Health Parity and Addiction Equity Act of 2008, which requires medical insurance plans to provide the same coverage for substance-use disorders and other mental illnesses that is provided for other illnesses, 5 and the proposed bipartisan Senate legislation that From the National Institute on Drug Abuse (N.D.V.) and the National Institute of Alcohol Abuse and Alcoholism (G.F.K.) — both in Bethesda, MD; and the Treatment Research Institute, Philadelphia (A.T.M.). Address reprint requests to Dr. Volkow at the National Institute on Drug Abuse, 6001 Executive Bld., Rm. 5274, Bethesda, MD 20892, or at nvolkow@ nida . nih . gov.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is a growing consensus that SUDs, once developed, tend to be chronic disorders 161 , reflecting long- lasting changes in brain function 50,51 , that are exacerbated by the cumulative mental health and social consequences that they trigger.”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The transition from controlled drug use into addiction mani fests itself in a repetitive cycle of intoxication, withdrawal and craving 49 , occurring along with a deterioration of mood that the addicted individual experiences as dysphoria/depression, anxi ety, irritability and anhedonia when not intoxicated 50 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal models have shown that both ethanol intake and anticipation prompt dopamine release in the NAc, impacting the mesocorticolimbic system associated with craving, reward, and behavioral control”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“emerging evidence has pointed out that addiction is in fact associated with structural and functional brain alterations, including deficits in reward, attention, memory and motivation mechanisms (3)”
From Addiction Psychotherapy: Going Beyond Self-Medication (2022) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further research demonstrated the reciprocal nature of these neurobiological deficits, suggesting that they serve both as a cause for addiction, in predisposing individuals toward the onset of addiction, and as the effect of addiction, in further altering some neurobiological mechanisms, and even genetics, following intensive and prolonged intoxication (4).”
From Addiction Psychotherapy: Going Beyond Self-Medication (2022) · cites this paper as [4]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Case–control neuroimaging studies of the brain with high-resolution provide early evidence for altered brain integrity in brain regions with a high density of CB1 receptors in heavy cannabis users [75].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [75]
Experimental — accuracy not yet measuredIn the citing paper
“The primary subcortical brain target is the nucleus accumbens (NAc) which is considered the center of the reward circuitry and heavily implicated in substance use and craving [18–22].”
In the citing paper
“CRH affects hormones involved in the stress response, including cortisol, and has been associated with the stress response and relapse to drug taking in animals39,40.”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Durlak, J. A., Weissberg, R. P., Dymnicki, A. B., Taylor, R. D., & Schellinger, K. B. (2011) · Child Development · doi:10.1111/j.1467-8624.2010.01564.x · Cited by 10,854
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citationBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Goldstein, R. Z., & Volkow, N. D. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3119 · Cited by 2,749
Self-citationGetting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Synaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397
The brain on drugs: from reward to addiction
Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306
Self-citationCocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Childress, A.-R., Jayne, M., Ma, Y., & Wong, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-06.2006 · Cited by 1,164
Self-citation
Research works printed but not linked: 2
- Busch SH, 2014, Am J Manag Care, 20, 76
- 10.15288/jsads.2014.75.108 · DOI
Cited by
Sorted by citations
Items 101–200 of 1,002
Recent Efforts to Dissect the Genetic Basis of Alcohol Use and Abuse
Sanchez‐Roige, S., Palmer, A. A., & Clarke, T. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.011 · Cited by 97
Hunger and Satiety Gauge Reward Sensitivity
Cassidy, R. M., & Tong, Q. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00104 · Cited by 93
The long-term effects of cocaine use on cognitive functioning: A systematic critical review
Frazer, K. M., Richards, Q., & Keith, D. R. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.04.005 · Cited by 105
Q: Is Addiction a Brain Disease or a Moral Failing? A: Neither
Heather, N. (2017) · Neuroethics · doi:10.1007/s12152-016-9289-0 · Cited by 96
Barnett, A. I., Hall, W., FRY, C. L., Dilkes‐Frayne, E., & Carter, A. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12632 · Cited by 97
Chronic tobacco smoking and neuropsychological impairments: A systematic review and meta-analysis
Conti, A. A., McLean, L., Tolomeo, S., Steele, J. D., & Baldacchino, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.017 · Cited by 107
Targeting the Barriers in the Substance Use Disorder Continuum of Care With Peer Recovery Support
Stanojlović, M., & Davidson, L. (2021) · Substance Abuse: Research and Treatment · doi:10.1177/1178221820976988 · Cited by 93
Development of short-form and screening cutoff point of the Smartphone Addiction Inventory (SPAI-SF)
Lin, Y., Pan, Y., Lin, S., & Chen, S. (2016) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1525 · Cited by 97
Neuroimaging in alcohol use disorder: From mouse to man
Fritz, M., Klawonn, A. M., & Zahr, N. M. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24423 · Cited by 89
Innate Immune Signaling and Alcohol Use Disorders
Coleman, L. G., & Crews, F. T. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_92 · Cited by 97
Bruns, N., Tressler, E. H., Vendruscolo, L. F., Leggio, L., & Farokhnia, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107312 · Cited by 92
Kelly, J. F., Greene, M. C., & Abry, A. (2021) · Addiction · doi:10.1111/add.15333 · Cited by 88
“‘chronically relapsing brain disease’, ‘disorder’) has been adopted and deployed explicitly by US federal public health agencies [6] [e.”
BackgroundBarreno, E. M., Domínguez‐Salas, S., Díaz, C., Lozano, O. M., Marín, J. A. L., & Verdejo‐García, A. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.10.004 · Cited by 92
Associations between butane hash oil use and cannabis-related problems
Meier, M. H. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.015 · Cited by 91
Alcohol use and personality trait change: pooled analysis of six cohort studies
Hakulinen, C. A., & Jokela, M. M. (2018) · Psychological Medicine · doi:10.1017/s0033291718000636 · Cited by 90
Chiu, Y., Pan, Y., & Lin, Y. (2018) · Journal of Behavioral Addictions · doi:10.1556/2006.7.2018.92 · Cited by 85
Midbrain circuit regulation of individual alcohol drinking behaviors in mice
Juarez, B., Morel, C., Ku, S. M., Liu, Y., Zhang, H., Montgomery, S. E., Gregoire, H., Ribeiro, E., Crumiller, M., Roman-Ortiz, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02365-8 · Cited by 86
Embodying addiction: A predictive processing account
Miller, M., Kiverstein, J. D., & Rietveld, E. (2019) · Brain and Cognition · doi:10.1016/j.bandc.2019.105495 · Cited by 89
Bolloni, C., Panella, R., Pedetti, M., Frascella, A. G., Gambelunghe, C., Piccoli, T., Maniaci, G., Brancato, A., Cannizzaro, C., & Diana, M. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00133 · Cited by 88
Spagnolo, P. A., & Goldman, D. A. (2016) · Brain · doi:10.1093/brain/aww284 · Cited by 87
Geoffroy, P. A., Tebeka, S., Blanco, C., Dubertret, C., & Strat, Y. L. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.02.018 · Cited by 84
Magill, M., Tonigan, J. S., Kiluk, B. D., Ray, L. A., Walthers, J., & Carroll, K. M. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103648 · Cited by 89
Bourdier, L., Orri, M., Carré, A., Gearhardt, A. N., Romo, L., Dantzer, C., & Berthoz, S. (2017) · Appetite · doi:10.1016/j.appet.2017.10.013 · Cited by 90
Bechara, A., Berridge, K. C., Bickel, W. K., Morón, J. A., Williams, S. B., & Stein, J. S. (2019) · Psychological Science in the Public Interest · doi:10.1177/1529100619860513 · Cited by 82
Garland, E. L., Bryan, C. J., Nakamura, Y., Froeliger, B., & Howard, M. O. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4494-4 · Cited by 86
Non-pharmacological factors that determine drug use and addiction
Ahmed, S. H., Badiani, A., Miczek, K. A., & Müller, C. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.015 · Cited by 85
Hassan, A. N., Le Foll, B., Imtiaz, S., & Rehm, J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.012 · Cited by 80
Dark Times: The Role of Negative Reinforcement in Methamphetamine Addiction
May, A. C., Aupperle, R. L., & Stewart, J. L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00114 · Cited by 84
“, ventral striatum) and over-active stress-systems reflected by amygdala hyperactivation (8).”
BackgroundA biological framework for emotional dysregulation in alcohol misuse: from gut to brain
Carbia, C., Lannoy, S., Maurage, P., López‐Caneda, E., O’Riordan, K. J., Dinan, T. G., & Cryan, J. F. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00970-6 · Cited by 82
Recovery from addiction: Behavioral economics and value-based decision making.
Field, M., Heather, N., Murphy, J. G., Stafford, T., Tucker, J. A., & Witkiewitz, K. A. (2019) · Psychology of Addictive Behaviors · doi:10.1037/adb0000518 · Cited by 79
Müller, C. P. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.028 · Cited by 78
Dopamine ‘ups and downs’ in addiction revisited
Samaha, A., Khoo, S. Y., Ferrario, C. R., & Robinson, T. E. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.03.003 · Cited by 80
Evaluating the Brain Disease Model of Addiction
Heather, N., Field, M., Moss, A. C., & Satel, S. L. (2022) · Routledge eBooks · doi:10.4324/9781003032762 · Cited by 88
Alloy, L. B., & Nusslock, R. (2019) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2019.1567347 · Cited by 75
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease
Delpont, B., Lhommée, E., Klinger, H., Schmitt, E., Bichon, A., Fraix, V., Castrioto, A., Quésada, J.-L., Pélissier, P., Kistner, A., et al. (2017) · Movement Disorders · doi:10.1002/mds.27101 · Cited by 72
The transition to cocaine addiction: the importance of pharmacokinetics for preclinical models
Kawa, A. B., Allain, F., Robinson, T. E., & Samaha, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5164-0 · Cited by 74
Burns, J. A., Kroll, D. S., Feldman, D. E., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00626 · Cited by 75
Self-citationWu, L., Potenza, M. N., Zhou, N., Hedy Kober, A., Shi, X., Yip, S. W., Xu, J., Zhu, L., Wang, R., Liu, G., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.04.003 · Cited by 72
“Second, given that craving, difficulties in regulating negative emotions, and addictions may develop in a complex and interacting fashion (Skinner & Aubin, 2010; Volkow et al., 2016), the current intervention targets both craving and negative emotions, and such interventions may have greater efficacies than those targ…”
BackgroundGiannitrapani, K. F., Glassman, P. A., Vang, D., McKelvey, J., Day, R. T., Dobscha, S. K., & Lorenz, K. (2018) · BMC Family Practice · doi:10.1186/s12875-018-0783-9 · Cited by 70
Are animal models of addiction useful?
Field, M., & Kersbergen, I. (2019) · Addiction · doi:10.1111/add.14764 · Cited by 69
From controlled to compulsive drug-taking: The role of the habenula in addiction
Mathis, V., & Kenny, P. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.018 · Cited by 73
Blum, K., Febo, M., Fried, L., Li, M., Dushaj, K., Braverman, E. R., McLaughlin, T., Steinberg, B., & Badgaiyan, R. D. (2016) · Substance Use & Misuse · doi:10.1080/10826084.2016.1244551 · Cited by 69
Steele, V. R., Maxwell, A. M., Ross, T. J., Stein, E. A., & Salmeron, B. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01147 · Cited by 67
Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders
Adams, J. M., & Volkow, N. D. (2020) · The AMA Journal of Ethic · doi:10.1001/amajethics.2020.702 · Cited by 67
Self-citationCurrent and Emerging Treatments for Methamphetamine Use Disorder
Moszczyńska, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210803091637 · Cited by 72
“Although the neurocircuitries involved in cue-, drug-, and stress-induced reinstatement of drug seeking contain several neurotransmitters and are distinct in a number of aspects, they converge on pathways involving glutamatergic projection from the dorsomedial prefrontal cortex to the core of the nucleus accumbens [40…”
Sex as a biological variable: Drug use and abuse
Riley, A. L., Hempel, B. J., & Clasen, M. M. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.10.005 · Cited by 66
Deeb, W., Giordano, J. J., Rossi, P. J., Mogilner, A. Y., Gunduz, A., Judy, J. W., Klassen, B. T., Butson, C. R., van Horne, C. G., Deny, D., et al. (2016) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2016.00038 · Cited by 69
Kawa, A. B., Valenta, A. C., Kennedy, R. T., & Robinson, T. E. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14418 · Cited by 65
Hyshka, E., Morris, H. M., Anderson-Baron, J. T., Nixon, L. L., Dong, K. A., & Salvalaggio, G. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.025 · Cited by 66
Wiss, D. A., Avena, N., & Gold, M. (2020) · Nutrients · doi:10.3390/nu12113521 · Cited by 66
Bach, P., Luderer, M., Müller, U. J., Jakobs, M., Baldermann, J. C., Voges, J., Kiening, K., Lux, A., Visser-Vandewalle, V., the DeBraSTRA study group, et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02337-1 · Cited by 65
Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic
Severino, A. L., Shadfar, A., Hakimian, J. K., Crane, O., Singh, G., Heinzerling, K. G., & Walwyn, W. M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00119 · Cited by 67
Chen, W. J., Wu, S., Tsay, W., Chen, Y., Hsiao, P., Yu, Y.-H., Ting, T.-T., Chen, C., Tu, Y., Huang, J., et al. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.07.003 · Cited by 65
Gandy, S., Forstmann, M., Carhart-Harris, R. L., Timmermann, C., Luke, D. P., & Watts, R. (2020) · Health Psychology Open · doi:10.1177/2055102920978123 · Cited by 70
“…and is strongly associated with mood and anxiety disorders (Hofmann et al., 2012), substance craving (Martel et al., 2014; Schlauch et al., 2013; Sinha and O’Malley, 1999; Volkow et al., 2016; Witkiewitz and Villarroel, 2009) and with rumination in depression (Iqbal and Dark, 2015; Thomsen, 2006).”
BackgroundThe Cambridge Handbook of Substance and Behavioral Addictions
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591 · Cited by 64
Liu, X., Zhao, X., Liu, T., Liu, Q., Tang, L., Zhang, H., Luo, W., Daskalakis, Z. J., & Yuan, T. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102809 · Cited by 63
Gueguen, M. C. M., Schweitzer, E. M., & Konova, A. B. (2020) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2020.08.007 · Cited by 67
The role of the orbitofrontal cortex and the nucleus accumbens for craving in alcohol use disorder
Bracht, T., Soravia, L. M., Moggi, F., Stein, M., Grieder, M., Federspiel, A., Tschuemperlin, R. M., Batschelet, H. M., Wiest, R., & Denier, N. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01384-w · Cited by 66
Temporal discounting as a candidate behavioral marker of obesity
Bickel, W. K., Lemos, R. F., Tomlinson, D. C., Craft, W. H., Keith, D. R., Athamneh, L. N., Basso, J. C., & Epstein, L. H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.035 · Cited by 68
Rundle, S. M., Cunningham, J. A., & Hendershot, C. S. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13244 · Cited by 61
England, K. J., Edwards, A. L., Paulson, A. C., Libby, E. P., Harrell, P. T., & Mondejar, K. A. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106664 · Cited by 61
Quigley, J. M., Ryan, S. A., Camenga, D. R., Patrick, S. W., Plumb, J., & Walker-Harding, L. (2019) · PEDIATRICS · doi:10.1542/peds.2019-1356 · Cited by 62
Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis
Baron, D., Blum, K., Chen, A., Gold, M. S., & Badgaiyan, R. D. (2018) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2018.026 · Cited by 60
Wakefield, J. C. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112665 · Cited by 60
Protein Translation and Psychiatric Disorders
Laguesse, S., & Dorit Ron, A. (2019) · The Neuroscientist · doi:10.1177/1073858419853236 · Cited by 58
Annual Research Review: Neuroimmune network model of depression: a developmental perspective
Nusslock, R., Alloy, L. B., Brody, G. H., & Miller, G. E. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13961 · Cited by 67
“This cascade affects the rewarding properties of drugs, promoting tolerance to the drug (Volkow et al., 2016, 2017).”
InfluentialWitkiewitz, K. A., & Tucker, J. A. (2024) · Addiction Research & Theory · doi:10.1080/16066359.2024.2329580 · Cited by 66
“Instead, the field has moved toward greater emphasis on brain disease models (Goldstein and Volkow 2011; Volkow et al. 2016; Heilig et al. 2021) or psychological states (e.g. anxiety, craving, cognitive expectancies) that immediately precede discrete substance use episodes (Marlatt and Gordon 1985;…”
Clinical Management of Opioid Withdrawal.
Torres‐Lockhart, K. E., Lu, T. Y., Weimer, M. B., Stein, M. R., & Cunningham, C. O. (2022) · Addiction · doi:10.1111/add.15818 · Cited by 57
Versace, F., Engelmann, J. M., Deweese, M. M., Robinson, J. D., Green, C. E., Lam, C. Y., Minnix, J. A., Karam‐Hage, M., Wetter, D. W., Schembre, S. M., et al. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx002 · Cited by 61
Clay, J. M., & Parker, M. O. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5027-0 · Cited by 65
Neuromarkers for Mental Disorders: Harnessing Population Neuroscience
Jollans, L., & Whelan, R. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00242 · Cited by 56
Dopaminergic signaling of uncertainty and the aetiology of gambling addiction
Zack, M. H., George, R. S., & Clark, L. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109853 · Cited by 62
Klugah‐Brown, B., Zhou, X., Pradhan, B., Zweerings, J., Mathiak, K., Biswal, B. B., & Becker, B. (2021) · Addiction Biology · doi:10.1111/adb.12997 · Cited by 59
Subthalamic low-frequency oscillations predict vulnerability to cocaine addiction
Degoulet, M., Tiran‐Cappello, A., Combrisson, E., Baunez, C., & Pelloux, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024121118 · Cited by 53
“This offers a relevant model to study one of the core features of drug addiction in humans (8, 9), which enables critical advances in characterizing brain cellular and molecular alterations following extended cocaine access and exposure to punishment paradigms, notably in neuronal activity and neuroplasticity (2, 10–1…”
BackgroundRolland, B., D’Hondt, F., Montègue, S., Brion, M., Peyron, E., Ternay, J. D. D., de Timary, P., Nourredine, M., & Maurage, P. (2019) · Neuropsychology Review · doi:10.1007/s11065-018-9395-3 · Cited by 56
DARK Classics in Chemical Neuroscience: Methamphetamine
Abbruscato, T. J., & Trippier, P. C. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00123 · Cited by 55
Abnormal frontostriatal tracts in young male tobacco smokers
Yuan, K., Yu, D., Zhao, M., Li, M., Wang, R., Li, Y., Manza, P., Kojori, E. S., Wiers, C. E., Wang, G., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.08.046 · Cited by 56
Liu, F., Cui, J., Liu, X., Chen, K. W., Chen, X., & Li, R. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02967-8 · Cited by 56
“Dependence drugs affect the midbrain dopamine system by stimulating the release as well as inhibiting the uptake of dopamine [5, 6].”
BackgroundClinical Psychological Science
Lilienfeld, S. O. (2016) · Clinical Psychological Science · doi:10.1177/2167702616673363 · Cited by 55
Medicaid benefits for addiction treatment expanded after implementation of the Affordable Care Act
Andrews, C. M., Grogan, C. M., Smith, B. T., Abraham, A. J., Pollack, H. A., Humphreys, K., Westlake, M. A., & Friedmann, P. D. (2018) · Health Affairs · doi:10.1377/hlthaff.2018.0272 · Cited by 54
Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Nolan, R. A., Reeb, K. L., Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., & Gaskill, P. J. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100030 · Cited by 54
Drug addiction: An affective-cognitive disorder in need of a cure
Fattore, L., & Diana, M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.006 · Cited by 58
Ahmadi‐Soleimani, S. M., Azizi, H., Gompf, H. S., & Semnanian, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.024 · Cited by 54
Shared Neural Correlates Underlying Addictive Disorders and Negative Urgency
Um, M., Whitt, Z. T., Revilla, R., Hunton, T., & Cyders, M. A. (2019) · Brain Sciences · doi:10.3390/brainsci9020036 · Cited by 53
Luján, M. Á., Cantacorps, L., & Valverde, O. (2019) · Addiction Biology · doi:10.1111/adb.12778 · Cited by 54
“Cocaine addiction is a chronic, relapsing disease characterized by compulsive drug use and seeking, despite its harmful consequences.(1)”
BackgroundZahrai, K., Veer, E., Ballantine, P. W., de Vries, H. P., & Prayag, G. (2022) · Journal of Consumer Affairs · doi:10.1111/joca.12449 · Cited by 53
Jones, A. K., Ngaimisi, E., Gopalakrishnan, M., Young, M. A., & Laffont, C. M. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00957-0 · Cited by 53
Oscillotherapeutics – Time-targeted interventions in epilepsy and beyond
Takeuchi, Y., & Berényi, A. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.01.002 · Cited by 53
“After establishment of maladaptation (addicted state), negative reinforcement caused by relief of anxiety, stress, and/or restlessness during abstinence will be a drive for further intake (Volkow et al., 2016).”
BackgroundGene expression profiling in the human alcoholic brain
Warden, A. S., & Mayfield, R. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.017 · Cited by 53
New developments in managing opioid addiction: impact of a subdermal buprenorphine implant
Itzoe, M. S. M., & Guarnieri, M. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s109331 · Cited by 52
Medication development in opioid addiction: Meaningful clinical end points
Volkow, N. D., Woodcock, J., Compton, W. M., Throckmorton, D. C., Skolnick, P., Hertz, S. H., & Wargo, E. M. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2595 · Cited by 52
Self-citationStriato-cortical tracts predict 12-h abstinence-induced lapse in smokers
Yuan, K., Zhao, M., Yu, D., Manza, P., Volkow, N. D., Wang, G., & Tian, J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0182-x · Cited by 52
Self-citationBeneficial and detrimental effects of genetic explanations for addiction
Lebowitz, M. S., & Appelbaum, P. S. (2017) · International Journal of Social Psychiatry · doi:10.1177/0020764017737573 · Cited by 50
Bayassi-Jakowicka, M., Lietzau, G., Czuba, E., Patrone, C., & Kowiański, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052618 · Cited by 55
The Genetically Informed Neurobiology of Addiction (GINA) model
Bogdan, R., Hatoum, A. S., Johnson, E. C., & Arpana Agrawal, A. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00656-8 · Cited by 56
Correa-Iriarte, S., Hidalgo-Fuentes, S., & Vilar, M. M. (2023) · Behavioral Sciences · doi:10.3390/bs13100839 · Cited by 66
“As Zhang and Wu [95] point out, it has been shown that addictive behaviours can alter brain circuits related to self-regulation such as prefrontal cortex functioning and top-down control [96–100].”
BackgroundAloi, J. M., Blair, K. S., Crum, K. I., Meffert, H., White, S. F., Tyler, P. M., Thornton, L. C., Mobley, A. M., Killanin, A. D., Adams, K. O., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.06.005 · Cited by 55
Boosting psychological change: Combining non-invasive brain stimulation with psychotherapy
Tatti, E., Phillips, A., Paciorek, R., Romanella, S. M., Dèttore, D., Lorenzo, G. D., Ruffini, G., Rossi, S., & Santarnecchi, E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104867 · Cited by 54
Holla, B., Biswal, J., Ramesh, V., Shivakumar, V., Bharath, R. D., Benegal, V., Venkatasubramanian, G., Chand, P., & Murthy, P. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109950 · Cited by 55
What Is an Addictive Disorder?
Blanco, C., Compton, W. M., & Lopez, M. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4356 · Cited by 50
Metadata
- Authors
- Volkow, N. D., Koob, G. F., & McLellan, A. T.
- Affiliations
- National Institute on Drug Abuse (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
- Treatment Research Institute (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-01-28
- Volume
- 374
- Issue
- 4
- Pages
- 363-371
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6135257
- OpenAlex
- W2283026346
- Cited by
- 2,008
- References
- 52
- Citations by year
- 2026: 264 · 2025: 198 · 2024: 172 · 2023: 193 · 2022: 179 · 2021: 208 · 2020: 245 · 2019: 160 · 2018: 154 · 2017: 178 · 2016: 54
- FWCI
- 19.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99‐AA999999)
- National Institute on Drug Abuse
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- brain disease model of addiction, neurobiology of addiction, substance use disorders, conditioned response, stress reactivity, drug craving, executive function, relapse, behavioral addiction, addiction genetics, social environment, addiction prevention, addiction treatment, public health policy, Mental Health Parity and Addiction Equity Act
- MeSH terms
- Brain Diseases, Humans, Models, Neurological, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
